As pharmaceutical companies increasingly rely on CDMOs to deliver complex therapies and expand manufacturing capacity, strong partnerships have never been more critical. These relationships play a vital role in ensuring life-saving medicines reach patients safely and on time.
But what does a successful partnership really look like from both sides?
In this candid panel discussion, leaders from pharmaceutical companies and CDMOs will share their perspectives on what drives long-term collaboration. From reliability, communication, and quality to commercial negotiations, innovation, and sustainability, we will explore how expectations are evolving and what both organisations can do to build stronger, more resilient, partnerships.
Join our panellists as we ask them:
- In your opinion, what are the three most important qualities of a successful pharma–CDMO partnership?
- How can both parties navigate challenges around cost, quality, risk, and ownership while maintaining trust?
- To share lessons learned from partnerships that succeeded (or failed) and how have those experiences shaped future collaborations?